Federal Supply Schedule GS07F6002R
Award Date
8/5/05
Last Date to Order
8/4/10
Funding Federal Agency
Not listed
Contracting Federal Agency
Federal Acquisition Service
Ultimate Awardee
Lovelace Biomedical Research Institute
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract, valued at a ceiling of $136,588,701, is for evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases. The contract is a single-award indefinite delivery vehicle with a period of performance from...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Lovelace Biomedical Research Institute a single award indefinite delivery contract with a potential value of $100 million. The contract aims to procure biological animal model and medical countermeasure development services through flexible contracting solutions. Lovelace Biomedical will utilize its expertise to assist the agency in oversight of its Indefinite Delivery Indefinite...
This indefinite delivery contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to the Lovelace Biomedical Research Institute. The $45,000,000 single-award contract runs through July 31, 2025 and is for the development of animal models to evaluate medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded an $80 million Indefinite Delivery Contract (IDC) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for preclinical models of infectious diseases research from 2017 to 2024. LBERI, doing business as Inhalation Toxicology Research Institute, is a non-profit contract research organization that provides expertise in areas such as inhalation toxicology, infectious disease modeling, and medical...
This federal contract IDV, awarded by the U.S. Navy to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), provides a wide range of preclinical research services and support to help develop treatments and cures for respiratory diseases, infectious diseases, and other medical conditions. The $497 million multiple-award Navy Medicine R&D Support Omnibus III IDIQ contract vehicle has facilitated numerous delivery orders for LBERI, a subsidiary of the Lovelace Biomedical...
The Lovelace Biomedical Research Institute has been awarded an indefinite delivery contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. With a potential value of $150 million, this single award IDV enables NIAID to procure preclinical product development services for candidate products from Lovelace through July 2023. Under the IDV, Lovelace has received a $486,301 cost-plus-fixed-fee delivery order to transfer, validate and qualify bioanalytical...
The National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $6.5 million single-award Indefinite Delivery Contract (IDC) to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization, to assess potential treatments for drug-induced respiratory depression and overdose toxicity. The contract has a period of performance from September 26, 2022 to September 25, 2027. Under this IDC, NIDA has issued several cost-plus-fixed-fee delivery...
This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Lovelace Biomedical Research Institute, a not-for-profit contract research organization based in Albuquerque, New Mexico. The $17.89 million multiple-award contract, which runs through April 2025, is for contract research organization (CRO) support for NCATS' medicinal chemistry work focused on lead optimization. Under the...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Lovelace Biomedical Research Institute to provide preclinical development support for candidate products and drug development activities for HIV, hepatitis, and tuberculosis. The 7-year, $107.3 million contract covers a range of services across seven task areas, including in vitro screening,...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order GS07F6002R-N0024406F0674 |
--
| Lovelace Biomedical And Environmental Research Institute, Inc. | $0 | 4/26/06 | 4/30/07 | 4/26/06 |
Delivery Order GS07F6002R-HHSD2002004F09796 | Lovelace Biomedical And Environmental Research Institute, Inc. | $1.6m | 8/21/04 | 5/1/08 | 2/4/11 |